Clinical Trial Update: Dasotraline Binge Eating Disorder Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for dasotraline in Binge Eating Disorder showing completed Phase 2 and Phase 3 studies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Binge Eating Disorder

Drugs mentioned

• Dasotraline (dasotraline)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Binge Eating Disorder | Phase 2, Phase 3 | Status: COMPLETED